Pencil Beam Scanning in Patients With Renal Tumors
This is a pilot study to assess acute toxicity in patients receiving flank irradiation using proton therapy for renal tumors.
Trial Details
- NCT ID
- NCT03810651
- Phase
- EARLY_PHASE1
- Sponsor
- Children's Hospital of Philadelphia
- Status
- RECRUITING
- Cancer Type
- Kidney Cancer
- Interventions
- Proton beam radiation using pencil beam scanning
- Locations (sample)
- Philadelphia, Pennsylvania, United States|39.95238,-75.16362
Key Eligibility Criteria
- Less than 30 years of age
- a. Any patient with Wilms tumor or clear cell sarcoma of the kidney who would require radiation therapy as standard of care including
- Any patient with favorable histology (FH), stage III disease
- Any patient with focal or diffuse anaplasia
For full eligibility, visit ClinicalTrials.gov.
Check If You May Be Eligible
Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.
Find Kidney Cancer Trials on Trialify →